文献速递急性肾损伤

巨噬细胞-内皮细胞免疫调节轴改善脓毒症急性肾损伤

A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury.
PubMed 文献 · Kidney Int · 2022-11-09

研究在脓毒症急性肾损伤小鼠模型中,通过白喉毒素选择性清除F4/80hi巨噬细胞,发现清除后24小时血清肌酐和组织学损伤评分加重,肾脏白细胞介素-6水平升高;单细胞RNA测序识别出巨噬细胞-内皮细胞免疫调节轴,F4/80hi巨噬细胞表达白细胞介素-1受体拮抗剂并限制内皮细胞白细胞介素-6生成,抗白细胞介素-6治疗可改善清除组小鼠的脓毒症急性肾损伤。

要点

  • 清除F4/80hi巨噬细胞加重脓毒症急性肾损伤,24小时血清肌酐和组织学损伤评分恶化。
  • F4/80hi巨噬细胞表达白细胞介素-1受体拮抗剂,限制内皮细胞白细胞介素-6生成。
  • 抗白细胞介素-6治疗可改善F4/80hi巨噬细胞清除小鼠的脓毒症急性肾损伤。

核心结论

  • F4/80hi巨噬细胞通过表达白细胞介素-1受体拮抗剂并限制内皮细胞产生白细胞介素-6来限制脓毒症急性肾损伤,代表脓毒症急性肾损伤中可靶向的细胞间通讯。

研究设计与样本

  • 研究使用CD11cCre(+)/CX3CR1dtr/wt(F4/80 MKO)小鼠与CD11cCre(-)/CX3CR1dtr/wt(F4/80 MWT)小鼠,通过白喉毒素注射清除F4/80hi巨噬细胞。
  • F4/80 MWT和F4/80 MKO小鼠接受假手术或盲肠结扎穿刺诱导脓毒症。

主要发现

  • 与F4/80 MWT小鼠相比,F4/80 MKO小鼠在24小时脓毒症急性肾损伤加重,以血清肌酐和组织学损伤评分衡量。
  • F4/80 MKO小鼠肾脏白细胞介素-6水平更高。
  • 单细胞RNA测序识别出决定白细胞介素-6表达的巨噬细胞-内皮细胞免疫调节轴。
  • F4/80hi巨噬细胞表达白细胞介素-1受体拮抗剂并限制内皮细胞白细胞介素-6表达。
  • 抗白细胞介素-6治疗改善了F4/80 MKO小鼠的脓毒症急性肾损伤。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The most common cause of acute kidney injury (AKI) in critically ill patients is sepsis. Kidney macrophages consist of both F4/80hi and CD11bhi cells. The role of macrophage subpopulations in septic AKI pathogenesis remains unclear. As F4/80hi macrophages are reported to contribute to immunomodulation following injury, we hypothesized that selective depletion of F4/80hi macrophages would worsen septic AKI. F4/80hi macrophages were depleted via diphtheria toxin injection in CD11cCre(+)/CX3CR1dtr/wt (F4/80 MKO mice) compared to CD11cCre(-)/CX3CR1dtr/wt (F4/80 MWT) mice. F4/80 MWT and F4/80 MKO mice were subjected to sham or cecal ligation and puncture to induce sepsis. Compared to F4/80 MWT mice, F4/80 MKO mice displayed worsened septic AKI at 24 hours as measured by serum creatinine and histologic injury scoring. Kidneys from F4/80 MKO mice elaborated higher kidney interleukin-6 levels. Mechanistically, single cell RNA sequencing identified a macrophage-endothelial cell immunoregulatory axis that underlies interleukin-6 expression. F4/80hi macrophages expressed interleukin-1 receptor antagonist and limited interleukin-6 expression in endothelial cells. In turn, anti-interleukin-6 therapy ameliorated septic AKI in F4/80 MKO mice. Thus, F4/80hi macrophages express interleukin-1 receptor antagonist and constrain interleukin-6 generation from endothelial cells to limit septic AKI, representing a targetable cellular crosstalk in septic AKI. These findings are particularly relevant owing to the efficacy of anti-interleukin-6 therapies during COVID-19 infection, a disease associated with high rates of AKI and endothelial dysfunction.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Privratsky JR, Ide S, Chen Y, et al. A macrophage-endothelial immunoregulatory axis ameliorates septic acute kidney injury. Kidney Int. 2022. PMID: 36334787. doi:10.1016/j.kint.2022.10.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。